Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Diaceutics PLC

Market Cap 121M 162M 140M 129M 226M 15.39B 230M 1.52B 593M 7.49B 608M 595M 25.94B P/E Ratio 2025 *
-
P/E Ratio 2026 * -
Enterprise Value 111M 149M 129M 119M 208M 14.19B 212M 1.4B 547M 6.91B 560M 548M 23.91B EV / Sales 2025
2.64x
EV / Sales 2026 * 2.4x
Free-Float
71.33%
Yield 2025 *
-
Yield 2026 * -
1 day-2.44%
1 month+19.76%
3 months+19.76%
6 months+46.28%
Current year+46.28%
1 month 2
Extreme 2
2.05
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.05
Extreme 1.05
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 162M
+4.55%+2.00%+393.02%+1,126.82% 59.49B
+0.82%-7.40%+21.95%+38.81% 3.94B
-1.09%-14.85%+26.49%+86.17% 3.28B
+2.61%-4.29%-31.77%+15.87% 1.35B
+1.37%-2.72%-20.98%-56.83% 1.3B
0.00%-1.65%+30.96%+236.62% 1.22B
+4.48%+0.38%-29.07%+40.88% 1.13B
-0.83%-4.75%-30.79%-55.78% 1.07B
Average +1.05%-2.69%+44.98%+179.07% 9.1B
Weighted average by Cap. +3.83%+0.93%+322.23%+929.96%

Financials

2025 2026 *
Net sales 38.5M 51.68M 44.64M 41.13M 72.16M 4.91B 73.28M 486M 189M 2.39B 194M 190M 8.28B 47M 63.09M 54.49M 50.21M 88.08M 6B 89.45M 593M 231M 2.92B 237M 232M 10.11B
Net income -400K -537K -464K -427K -750K -51.03M -761K -5.05M -1.97M -24.84M -2.02M -1.97M -86.01M -1.1M -1.48M -1.28M -1.18M -2.06M -140M -2.09M -13.88M -5.41M -68.31M -5.54M -5.42M -237M
Net Debt -9.44M -12.67M -10.94M -10.08M -17.69M -1.2B -17.96M -119M -46.42M -586M -47.55M -46.54M -2.03B -7.71M -10.35M -8.94M -8.24M -14.45M -984M -14.67M -97.26M -37.92M -479M -38.84M -38.01M -1.66B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.425GBP
Average target price
2.130GBP
Spread / Average Target
+49.47%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!